Immunovo

Recent Finacing

Seed

Recent Raise

Undisclosed

Immunovo BV is a Dutch biotechnology company developing immunotherapeutic drugs using a Pepscan-derived peptide platform that combines novel immunotherapy methods with oncology insights.